BUDGET IMPACT ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR HEAMOPHILIA A PATIENTS WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Souza, P. [1 ]
Puopolo, G. R. [1 ]
Leme-Souza, R. [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Sao Paulo, SP, Brazil
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO36
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB VERSUS BYPASSING AGENTS IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Souza, P.
    Puopolo, G. R.
    Leme-Souza, R.
    VALUE IN HEALTH, 2019, 22 : S847 - S847
  • [2] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A PATIENTS WITH INHIBITORS: A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS
    Cortesi, P. A.
    Castaman, G.
    Trifiro, G.
    Ferrario, M.
    Improta, G.
    Mazzaglia, G.
    Molinari, A. C.
    Mantovani, L. G.
    VALUE IN HEALTH, 2019, 22 : S845 - S845
  • [3] BUDGET IMPACT ANALYSIS OF TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Holanda, P.
    Salgado De Santana, C.
    Senna, T.
    Carmo, L.
    Alexandre, R. F.
    VALUE IN HEALTH, 2021, 24 : S96 - S97
  • [4] Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With Inhibitors
    Watanabe, Alexandre Hikiji
    Lee, Shaun Wen Huey
    Chai-Adisaksopha, Chatree
    Lim, Ming Y.
    Chaiyakunapruk, Nathorn
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 28 : 7 - 13
  • [5] Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors
    Cortesi, Paolo Angelo
    Castaman, Giancarlo
    Trifiro, Gianluca
    Creazzola, Simona Serao
    Improta, Giovanni
    Mazzaglia, Giampiero
    Molinari, Angelo Claudio
    Mantovani, Lorenzo Giovanni
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 216 - 228
  • [6] BUDGET IMPACT ANALYSIS OF TOFACITINIB FOR RHEUMATOID ARTHRITIS FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Ferreira, C. N.
    Rufino, C. S.
    Santana, C. F.
    Dulcine, M.
    VALUE IN HEALTH, 2015, 18 (07) : A638 - A638
  • [7] BUDGET IMPACT ANALYSIS OF THE USE OF EMICIZUMAB IN PROPHYLAXIS FOR SEVERE HEMOPHILIA A AND INHIBITORS IN THE PEDIATRIC COPULATION OF THE DOMINICAN REPUBLIC
    Munoz, A.
    Bustamante, A.
    Blanco, J.
    VALUE IN HEALTH, 2022, 25 (12) : S135 - S136
  • [8] BUDGET IMPACT MODEL OF FEIBA IN THE MANAGEMENT OF HEMOPHILIA PATIENTS WITH INHIBITORS IN THE EGYPTIAN PUBLIC HEALTHCARE SYSTEM
    Anan, I
    El-Ekiaby, M.
    Hamdy, M.
    Elkholy, M. T.
    Afifi, R.
    Adel, R.
    Ibrahim, A.
    VALUE IN HEALTH, 2022, 25 (12) : S88 - S88
  • [9] BUDGET IMPACT RELATED TO COMPLICATIONS ON POST-BARIATRIC SURGERY PATIENTS IN BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    De Santana, Salgado C.
    Pititto, L.
    Gulart, A.
    Palmanhani, M. R.
    VALUE IN HEALTH, 2022, 25 (12) : S79 - S79
  • [10] LAPATINIB WITH LETROZOLE AS A TREATMENT STRATEGY FOR PATIENTS WITH METASTATIC BREAST CANCER (HER2) UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM: A BUDGET IMPACT ANALYSIS
    Guimaraes, J. M.
    Fonseca, M. C.
    Costa, D. N.
    Aragao, E. S.
    Abreu, G. R.
    Nita, M. E.
    VALUE IN HEALTH, 2017, 20 (05) : A98 - A98
12345